Cancer Family
Urinary System Neoplasm
CI-CAN-00000379Explore in graph →
Non-malignant964 active trials28 approved drugs109 evidence items
- NCIt
- C3431
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000379Explore in graph →
Clinical trials
4,238 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02923557 | Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients | unknown | Phase 2 | 200 | Peking University First HospitalOTHER | 1 | Nov 17, 2016 | clinicaltrials |
| NCT02572804 | Comparing Rectus Sheath Catheter to Epidural Post Cystectomy | unknown | N/A | 160 | Vancouver Coastal HealthOTHER_GOV | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02951078 | A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer | unknown | Phase 3 | 172 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Nov 1, 2016 | clinicaltrials |
| NCT01529658 | Renal Hypothermia During Partial Nephrectomy | unknown | N/A | 184 | Ottawa Hospital Research InstituteOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT02924597 | Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage | unknown | N/A | 100 | RenJi HospitalOTHER | 1 | Oct 5, 2016 | clinicaltrials |
| NCT02828709 | Safety and Feasibility of IRE for SRMs | unknown | Phase 2 | 20 | Dr. Prof. M.P. Laguna PesOTHER | 1 | Sep 27, 2016 | clinicaltrials |
| NCT02886897 | A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors | unknown | Phase 1 / Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Sep 1, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02849119 | Transperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial Nephrectomy | unknown | N/A | 106 | Samsung Medical CenterOTHER | 1 | Jul 29, 2016 | clinicaltrials |
| NCT02360618 | Metformin and Simvastatin Use in Bladder Cancer | unknown | Phase 2 | 44 | London Health Sciences CentreOTHER | 1 | Jul 11, 2016 | clinicaltrials |
| NCT02787915 | DC1s-CTL Cellular Therapy for Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 50 | Xuzhou Medical UniversityOTHER | 0 | Jun 2, 2016 | clinicaltrials |
| NCT02774200 | A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients. | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | May 17, 2016 | clinicaltrials |
| NCT02734329 | Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage | unknown | N/A | 600 | RenJi HospitalOTHER | 1 | May 3, 2016 | clinicaltrials |
| NCT02072031 | Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC） | unknown | Phase 2 | 133 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Apr 26, 2016 | clinicaltrials |
| NCT02716961 | Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer | unknown | N/A | 208 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Mar 24, 2016 | clinicaltrials |
| NCT02398552 | A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma. | unknown | Phase 2 | 80 | Peking University Cancer Hospital & InstituteOTHER | 1 | Mar 1, 2016 | clinicaltrials |
| NCT02688491 | A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment | unknown | N/A | 300 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Feb 25, 2016 | clinicaltrials |
| NCT01924156 | DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT02659332 | Laser Treatment of Bladder Tumors in the Outpatient Department | unknown | N/A | 20 | Gregers G HermannOTHER | 1 | Jan 21, 2016 | clinicaltrials |
| NCT02287987 | CLamp vs Off Clamp Kidney During Partial Nephrectomy(CLOCK) | unknown | N/A | 200 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT02600481 | Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery | unknown | N/A | 280 | Huadong HospitalOTHER | 1 | Nov 10, 2015 | clinicaltrials |
| NCT02547350 | Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas | unknown | Phase 2 | 200 | Xuesong LiOTHER | 0 | Sep 11, 2015 | clinicaltrials |
| NCT02534623 | Postoperative Quality of Recovery After Transurethral Resection of the Bladder | unknown | N/A | 70 | General Hospital ZadarOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT02496442 | Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan | unknown | N/A | 30 | FlowmedINDUSTRY | 0 | Jul 14, 2015 | clinicaltrials |
| NCT02001493 | Metabolomic Profiling in Renal Cell Carcinoma | unknown | — | 60 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT02443844 | Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression | unknown | Phase 4 | 40 | Diskapi Teaching and Research HospitalOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT02278978 | BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma | unknown | Phase 2 | 129 | National Taiwan University HospitalOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT02417194 | Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell Carcinoma | unknown | — | 238 | Seoul National University HospitalOTHER | 1 | May 7, 2015 | clinicaltrials |
| NCT02422277 | Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy | unknown | Phase 2 | 60 | Mansoura UniversityOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT02186925 | A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. | unknown | — | 1,000 | Meir Medical CenterOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01914263 | Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection | unknown | Phase 1 | 40 | Alliancells-PuRui Biocience Co., Ltd.INDUSTRY | 1 | Apr 16, 2015 | clinicaltrials |
| NCT00949455 | A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium(LaMB) | unknown | Phase 2 / Phase 3 | 204 | Queen Mary University of LondonOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT02022787 | Value of Various Chemokines in the Detection and Follow up of RCC | unknown | — | 30 | Carmel Medical CenterOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01581723 | Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor | unknown | Phase 3 | 150 | Chinese University of Hong KongOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01791387 | 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC(DILIGENCE-1) | unknown | Phase 2 | 30 | Auckland District Health BoardOTHER_GOV | 1 | Feb 3, 2015 | clinicaltrials |
| NCT02345499 | Open Versus Laparoscopic Radical Cystectomy(OvsL) | unknown | Phase 2 | 80 | Azienda Ospedaliero-Universitaria Consorziale Policlinico di BariOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT02324803 | Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients | unknown | Phase 2 | 86 | Southern China Urology Cancer ConsortiumOTHER | 1 | Dec 24, 2014 | clinicaltrials |
| NCT01274273 | Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer | unknown | Phase 2 | 118 | University of AarhusOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT02298608 | Efficacy and Safety of IRE for RMs | unknown | Phase 1 / Phase 2 | 10 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01967407 | IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.(IRENE) | unknown | Phase 1 / Phase 2 | 20 | University of MagdeburgOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT02228473 | Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort | unknown | N/A | 76 | Seoul National University HospitalOTHER | 1 | Oct 28, 2014 | clinicaltrials |
| NCT01487915 | Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma(COACH) | unknown | Phase 2 | 80 | Asan Medical CenterOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01838720 | Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage | unknown | N/A | 90 | RenJi HospitalOTHER | 1 | Aug 13, 2014 | clinicaltrials |
| NCT02174185 | Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic Neobladders | unknown | — | 300 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT02208128 | Molecular Determinants for Therapy Response on Renal Cell Carcinoma(MORE) | unknown | N/A | 4 | Heidelberg UniversityOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT00003804 | Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor | unknown | Phase 3 | 350 | University of LeicesterOTHER | 15 | Jun 24, 2014 | clinicaltrials |
| NCT00047138 | Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | unknown | Phase 3 | 350 | University of LeicesterOTHER | 4 | Jun 24, 2014 | clinicaltrials |
| NCT01711268 | Sunitinib Drug Levels and Outcomes in Kidney Cancer(CRESTO) | unknown | — | 35 | Western Sydney Local Health DistrictOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT01381822 | Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors(TH-CR-410) | unknown | Phase 1 | 58 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 21, 2014 | clinicaltrials |
| NCT01577784 | Pazopanib in Second-line Therapy in Renal Cell Carcinoma | unknown | Phase 2 | 27 | Associació per a la Recerca Oncologica, SpainOTHER | 1 | Mar 12, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Nov 17, 2016source: clinicaltrials